Tiffany Burnett serves as the Senior Director of Biopharma Programs at the Cystic Fibrosis Foundation. In this role, she co-leads the Infection Research Initiative, and heads therapeutic development and industry efforts for the anti-infective portfolio. Tiffany is actively engaged in advancing the Foundation's commitment to diversity, equity, and inclusion initiatives. 
Tiffany joined the Foundation in 2020, with over twenty years of drug and product development experience in the biotechnology, pharmaceutical and life science industries within the therapeutic areas of oncology, vaccines, infectious disease, generics, and next generation sequencing.

 Throughout her career, Tiffany has held progressive global  leadership roles within research and development and commercial operations. She has been a key contributor to renowned organizations such as Astra Zeneca, Thermo Fisher Scientific, Novartis/Sandoz, Takeda, West Pharmaceutical Services, and Johnson & Johnson.

Tiffany earned her Bachelor of Science in Chemistry from Temple University and a Master of Science in Pharmacy from Temple University School of Pharmacy.

Outside of her professional endeavors, Tiffany finds fulfillment in spending quality times with her husband, two sons, and extended family. She also nurtures her passions for music, culture, gardening, cooking, and sports. She is committed to merging science and advocacy in a manner that brings about meaningful and impactful change for all.